Craneware

Craneware Equity

The The Equity of Craneware (CRW.L) as of Oct 11, 2026 is 320.31 M USD. In the previous year, The Equity was 337.56 M USD — a change of -5.11% (lower).

Equity

320.31 MUSD

YoY

-5.11%

Last updated:

In 2026, Craneware's equity was 320.31 M USD, a -5.11% increase from the 337.56 M USD equity in the previous year.

The Craneware Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
59.84 M USD
Jan 1, 2020
68.40 M USD
Jan 1, 2021
260.28 M USD
Jan 1, 2022
333.02 M USD
Jan 1, 2023
327.84 M USD
Jan 1, 2024
328.59 M USD
Jan 1, 2025
337.56 M USD
Jan 1, 2026
320.31 M USD
The Craneware Equity history
YEAREquityYoY
320.31 MUSD-5.11%
337.56 MUSD+2.73%
328.59 MUSD+0.23%
327.84 MUSD-1.56%
333.02 MUSD+27.95%
260.28 MUSD+280.55%
68.40 MUSD+14.31%
59.84 MUSD+15.86%
51.65 MUSD-12.99%
59.36 MUSD+12.40%
52.81 MUSD+10.87%
47.63 MUSD+6.04%
44.92 MUSD—
Access this data via the Eulerpool API

Craneware Stock analysis

What does Craneware do? Craneware PLC is a publicly traded company based in Edinburgh, Scotland, that specializes in the development and marketing of software solutions for the healthcare industry. The company was founded in 1999 and has been listed on the London Stock Exchange since 2007. The business model of Craneware is based on the development and marketing of software solutions for the healthcare industry that help customers optimize their financial and performance processes. Craneware focuses particularly on the area of Revenue Cycle Management (RCM), which involves the management of hospital billing and payment processes. Craneware's software solutions are used in various areas, including billing, pricing, contract management, compliance, and analytics. The products are modular and can be individually configured according to the customer's needs. One example of a product is the Revenue Integrity Management System (RIMS), which allows for comprehensive analysis of patient billing and ensures that hospitals maximize their revenue while complying with regulations. Other products include Reference Plus, which helps customers determine and stay competitive with pricing for medical services, and the Online Analytics Suite, which specializes in data analysis and reporting. Craneware is divided into different divisions, including North America, International, and UK & EMEA. North America is the largest market for the company, accounting for approximately 90% of its revenue. In North America, Craneware has a strong presence and works closely with many large hospitals and healthcare organizations. The company's focus on RCM solutions has received significant attention, and many customers appreciate the efficiency and effectiveness of the software solutions. In the International division, Craneware focuses on expanding its presence in Europe, Asia, Africa, and the Middle East. The company has already gained many partners in these regions and is working to further expand its market share. In the UK & EMEA division, Craneware primarily serves NHS hospitals (National Health Service) and offers a wide range of RCM solutions to its customers. Craneware was founded in 1999 by Edinburgh University graduate Gordon Craig. The company's headquarters were established in Edinburgh and quickly became a major employer in the city. In 2007, Craneware was listed on the London Stock Exchange and has since been a publicly traded company. In 2015, the company was included in the FTSE AIM 100 Index. In recent years, Craneware has experienced strong growth and expanded its market presence to different countries. The company plans to continue investing in research and development and focusing on innovation to provide its customers with the best RCM solutions in the future. Craneware is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Craneware's Equity

Craneware's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Craneware's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Craneware's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Craneware's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Craneware’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Craneware stock

The Equity of Craneware is 320.31 M USD in 2026.

The Equity of Craneware changed from 337.56 M USD to 320.31 M USD, representing a -5.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Craneware since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Craneware historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Craneware

All Key Metrics — Craneware